Nykode Therapeutics ASA
XBER:5VB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nykode Therapeutics ASA
XBER:5VB
|
NO |
|
V
|
Vast Resources PLC
SWB:D9A
|
UK |
|
Jupai Holdings Ltd
OTC:JPPYY
|
CN |
|
L
|
Loma Negra Compania Industrial Argentina SA
F:8LN
|
AR |
|
I
|
Ibstock PLC
F:2I5
|
UK |
|
Aferian PLC
F:DWJ
|
UK |
|
JR Holding Alternatywna Spolka Inwestycyjna SA
F:8JA
|
PL |
|
Mirum Pharmaceuticals Inc
F:08D
|
US |
|
Rainbow Rare Earths Ltd
F:RR1
|
GG |
|
CirChem AB
F:CRB
|
SE |
|
V
|
Vizsla Copper Corp
OTC:VCUFF
|
CA |
|
Nippon Chemi-Con Corp
F:NCZ
|
JP |
|
I
|
International Bancshares Corp
F:IB4
|
US |
|
Sichuan Energy Investment Development Co Ltd
F:84H
|
CN |
|
C
|
China Communications Services Corp Ltd
XMUN:CMW
|
CN |
|
A
|
Azenta Inc
XMUN:BA3
|
US |
|
U
|
UACJ Corp
F:F4M
|
JP |
|
H
|
Heritage Mining Ltd
F:Y66
|
CA |
|
C
|
China Yuchai International Ltd
XBER:CYD
|
SG |
|
Adventure Box Technology AB (publ)
F:799
|
SE |
|
Leslie's Inc
F:LE30
|
US |
|
A
|
American Vanguard Corp
F:AVJ
|
US |
|
J
|
Jupai Holdings Ltd
F:JP8A
|
CN |
|
C
|
Ceylon Graphite Corp
OTC:CYLYF
|
CA |
Dividends
Dividend Yield
Nykode Therapeutics ASA
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Nykode Therapeutics ASA
Payout Ratio
Nykode Therapeutics ASA
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 5VB is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
5VB Price
Nykode Therapeutics ASA
| Average Annual Return | -42.64% |
| Standard Deviation of Annual Returns | 43.99% |
| Max Drawdown | -99% |
| Market Capitalization | 1.3B EUR |
| Shares Outstanding | 326 546 000 |
| Percentage of Shares Shorted |
N/A
|
